Clifford Chance has advised Credit Suisse, Danareksa Sekuritas and UBS as joint global coordinators on the international aspects of the US$200 million (IDR 2.4 trillion) initial public offering and listing on the Indonesia Stock Exchange of PT Blue Bird Tbk, the Indonesian taxi operator. The company sold 376.5 million shares at US$0.68 (IDR 8,175) per share.
Danny Lim, Soh Chai Lih, Bernia Tan and Cynthia Wu from the Corporate & Capital Markets Practice acted for CITIC Limited ("CITIC") and (as joint counsel) CKM (Cayman) Company Limited ("Offeror") in the approximately S$1.9 billion pre-conditional voluntary offer for United Envirotech Ltd.. The Offeror is a consortium vehicle between CITIC and Kohlberg Kravis Roberts & Co. L.P. ("KKR").
Bankers Plc has listed on the First North Finland marketplace maintained by the Helsinki Stock Exchange. United Bankers is a Finnish midsized investment service group with four business areas: Asset Management, Fund Management, Brokerage and Investment Banking. At the end of June 2014, the assets under the management of the company totalled EUR 1.3 billion, and the company had nearly 4,500 clients.
Novartis Finance S.A. completed the placement of two EUR 600,000,000 Notes. The 2021 Notes were issued at 99.134% of its principal amount with a coupon of 0.750% and will mature on 9 November 2021 at its nominal value. The 2026 Notes were issued at 99.697% with a coupon of 1.625% and will mature on 9 November 2026 at its nominal value. Both Notes are guaranteed by Novartis AG. They are provisionally admitted to trading and expected to be listed on SIX Swiss Exchange Ltd.
AT&T Inc. announced the issuance of CHF 1,050,000,000 FATCA-compliant Bonds. Credit Suisse acted as sole lead manager. The bonds will be listed on the SIX Swiss Exchange.
Homburger acted as counsel to Credit Suisse. The Homburger team consisted of René Bösch (Partner, Financial Services) and Eduard De Zordi (Counsel, Financial Services).
Taylor Wessing has advised its client NoteMachine, one of the major cash machine operators in the UK and Germany, on its acquisition of Eurochange Ltd, a provider of specialist foreign currency and international payment solutions to retail and business customers.
The acquisition furthers NoteMachine's strategy of extending its range of transactional and payment services to retail, business and bank customers.
Slaughter and May, working as a team with Paul, Weiss, Rifkind, Wharton & Garrison LLP, advised Arrow Global Group plc (Arrow Global) on the issue by Arrow Global Finance plc of EUR 225 million senior secured floating rate notes. The notes are governed by New York law and were offered to investors in the US under a private placement exemption under the US Securities Act as well as to investors outside the US. Goldman Sachs International acted as sole bookrunner and global coordinator for the issue, with The Royal Bank of Scotland plc and Lloyds Bank plc as co-managers.
Herbert Smith Freehills is advising UBS AG, Australia Branch and CIMB Capital Markets (Australia) Ltd in relation to their role as bookrunners and joint lead managers of Centuria Property Funds Limited’s (as Responsible Entity of Centuria Metropolitan REIT No.1 and Centuria Metropolitan REIT No.2 (together, the Stapled Funds)) initial public offering of stapled securities in the Stapled Funds (IPO) and listing on the Australian Securities Exchange (ASX).
Allen & Overy said today that the EUR500 million issuance of covered bonds by Raiffeisenbank a.s., which marks the first public international Czech covered bond issuance, represents a landmark moment for Czech issuers in the international capital markets.
The covered bonds are issued under the bank’s EUR5 billion covered bond programme, established in 2012, and listed on the Luxembourg Stock Exchange.
Linklaters advised consortium banks, led by JP Morgan as Global Coordinator, in the successful IPO of Swiss biotechnology company Molecular Partners. The proposition also included an offer to institutional investors in the United States.
The offer price for the shares was 22.40 Swiss francs per share, representing a market capitalization of around 485 million Swiss francs. Listing of the shares of Molecular Partners and the first day of trading on the SIX Swiss Exchange took place on November 5, 2014.